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Abstract: Influenza A virus (IAV) infection remains a significant cause of morbidity and mortality
worldwide. One key transcription factor that is activated upon IAV infection is nuclear factor
Kappa B (NF-κB). NF-κB regulation involves the inhibitor proteins NF-κB inhibitor beta (NFKBIB),
(also known as IκBβ), which form complexes with NF-κB to sequester it in the cytoplasm. In
this study, microarray data showed differential expression of several microRNAs (miRNAs) on
exposure to IAV. Target scan analysis revealed that miR-4776, miR-4514 and miR-4742 potentially
target NFKBIB messenger RNA (mRNA). Time-course analysis of primary bronchial epithelial
cells (HBEpCs) showed that miR-4776 expression is increased within 1 h of infection, followed by
its downregulation 4 h post-exposure to IAV. NFKBIB upregulation of miR-4776 correlated with
a decrease in NFKBIB expression within 1 h of infection and a subsequent increase in NFKBIB
expression 4 h post-infection. In addition, miRNA ago-immunoprecipitation studies and the three
prime untranslated region (3’ UTR) luciferase assay confirmed that miR-4776 targets NFKBIB mRNA.
Furthermore, uninfected HBEpCs transfected with miR-4776 mimic showed decreased expression
of NFKBIB mRNA. Overexpression of NFKBIB protein in IAV infected cells led to lower levels of
IAV. Taken together, our data suggest that miRNA-4776 modulates IAV production in infected cells
through NFKBIB expression, possibly through the modulation of NF-κB.
Keywords: NFKBIB; influenza virus; bronchial epithelial cells; NF-κB; virus survival

1. Introduction
Influenza infection is a significant cause of morbidity and mortality causing an estimated
3–5 million infections per year [1]. Upon infection, the virus hijacks the host’s cellular machinery for
its survival and replication. One mechanism by which influenza may influence host gene expression is
through differential expression of host cell microRNAs (miRNA), which are endogenously produced
~22 nucleotide single-strand RNAs that interact with the three prime untranslated region (3’ UTR) of
messenger RNAs (mRNAs) and destabilize the transcripts or degrade them to repress translation [2].
These molecules have been shown to play a key role in the regulation of a diverse array of cellular
responses including inflammation and cell death. Since their initial discovery, miRNAs have been
developed as both diagnostic tools and therapeutic targets. A number of miRNAs identified are
predicted to target key elements of the immune response and cell survival pathways [3].

Viruses 2017, 9, 94; doi:10.3390/v9050094

www.mdpi.com/journal/viruses

Viruses 2017, 9, 94

2 of 18

Nuclear factor Kappa B (NF-κB) plays an important role in regulating several genes that are
necessary for cell proliferation, apoptosis and cell survival [4]. NF-κB also activates pro-inflammatory
genes in cells at the sites of inflammation in several diseases including infectious diseases [5,6].
In addition, NF-κB itself is activated upon influenza infection [7–9]. It was previously believed that
activation of NF-κB served as a cellular defense mechanism upon influenza viral infection with
production of inflammatory cytokines, including interferon β (IFNβ) [7,10]. Studies conducted in A549
and U1752 cells showed that low NF-κB activity were resistant to influenza A virus (IAV) infection,
but cells became susceptible to IAV upon activation of NF-κB. One suggested role of NF-κB signaling
is in the endocytosis pathway that is necessary for efficient influenza virus infection (9). Some of the
viral proteins are involved in the activation of NF-κB [11]. The viral non-structural protein NS1 acts
as a suppressor of NF-κB activation [12]. However, the antagonistic activity of NS1 is not exhaustive
for complete blocking of NF-κB [13]. Moreover, other viral components such as hemagglutinin [14],
nucleoprotein and matrix proteins can induce NF-κB activation [11]. In vitro studies showed that the
NF-κB specific inhibitor, SC75741, expressed in bronchial epithelial cells decreases the propagation of
IAV [15]. This effect was subsequently confirmed in an in vivo mouse model in which SC75741 was
able to effectively protect mice from the deadly effects of three highly pathogenic influenza strains.
Based on these studies, it is hypothesized that IAV has evolved a strategy to activate NF-κB to prevent
apoptosis of the host cell and facilitate viral replication.
Regulation of NF-κB is a complex process involving both internal and external cellular stimuli [16].
NF-κB regulation involves a family of inhibitor proteins, NF-κB inhibitor beta protein (NFKBIB, also
known as IκBβ) that forms a complex with NF-κB and sequesters it into the cytoplasm [17]. This
effectively prevents nuclear translocation of NF-κB and subsequent transcription of its target genes [18].
Phosphorylation of the serine residues on NFKBIB proteins directs them for degradation and releases
NF-κB from the complex resulting in its translocation to the nucleus [19]. Given that NF-κB plays a role
in influenza infection, our aim was to determine the role of specific miRNAs in regulating the NF-κB
pathway. In gastric cancer cell lines, miR-20a was shown to target NFKBIB [20], and miR-182-5p was
shown to target NFKBIB in breast cancer cells [21]. However, possibly due to tissue specific expression,
we saw no significant change in these miRNAs in IAV infected alveolar lung epithelial (A549) cells.
In our miRNA microarray analysis, we show that miR-4514, miR-4742, and miR-4776 are significantly
upregulated in IAV infected A549 cells and target scan [22] analysis showed that these miRNAs may
target NFKBIB mRNA. We show that these three miRNAs are differentially expressed in IAV infected
human primary bronchial epithelial cells (HBEpCs) and that miR-4776 specifically downregulates
expression of NFKBIB that leads to activation of NF-κB and increased survival of IAV in HBEpCs cells.
2. Materials and Methods
2.1. Cell Culture
HBEpCs were purchased from PromoCell GmbH (Heidelberg, Germany) and sub-cultured in
media and growth factors recommended by the supplier. A549 cells (CCL-34, American Type Culture
Collection (ATCC), Manassas, VA, USA) were cultured in standard F12K medium with heat inactivated
10% fetal bovine serum (FBS), 100 IU/mL penicillin and 100 µg/mL streptomycin sulfate. Madin–Darby
canine kidney (MDCK) cells were used for the propagation of influenza virus. MDCK cells were
cultured in Minimum Essential Medium (MEM) (ATCC) supplemented with 10% FBS, 100 IU/mL
penicillin and 100 µg/mL streptomycin sulfate [22].
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2.2. Viruses and Their Infections
Influenza virus A/WSN/33 (H1N1) was a kind gift from Prof. Robert A. Lamb (Northwestern
University, Chicago, IL, USA) and cultivation and maintenance of the virus was carried out as described
earlier [23].
All infections of airway epithelial cells were performed in six-well plates at a dose of
1.0 multiplicity of infection (MOI) unless otherwise specified. Controls referred are the cells that
were mock infected. Six-well plates were seeded with 5 × 105 cells per well and grown to 80%
confluence. Cells were rinsed with phosphate buffered saline (PBS), and then the virus diluted in
modified Hank’s Balanced Salt Solution (HBSS) was added to each well. After 45 min incubation at
37 ◦ C, excess virus was washed off with PBS. Fresh F12 media was added containing 1 µg/mL of tosyl
phenylalanyl chloromethyl ketone (TPCK)-trypsin (Sigma-Aldrich, St Louis, MO, USA) and incubated
at 37 ◦ C and 5% CO2 . TPCK was not added to A/WSN/33 virus. Cells were harvested at different
time intervals and used for protein and RNA studies.
2.3. Real-Time Reverse Transcription Polymerase Chain Reaction
After the experimental treatment of the HBEpCs and A549 cells total RNA was extracted from
these cells with the RNeasy plus Mini Kit (Qiagen, Germantown, MD, USA). RNA was quantified
with a NanoDrop spectrophotometer (Thermofisher Scientific, Foster City, CA, USA). Total RNA was
then reverse transcribed with the High-Capacity complementary DNA (cDNA) Reverse Transcription
Kit (Applied Biosystems, Foster City, CA, USA). All reverse transcription-polymerase chain reactions
(RT-PCRs) were carried out using standard TaqMan primers for NFKBIB (assay id # Hs00182115_m1),
NF-κB (assay ID# Hs00765730_m1), and glyceraldehyde phosphate dehydrogenase (GAPDH) (assay
ID # Hs03929097_g1), which were purchased from Applied Biosystems (Thermofisher Scientific). Fold
change in expression was determined using the ∆∆ct method after normalizing to GAPDH [22].
miRNA was isolated using the miReasy Kit (Qiagen) and analyzed by RT-PCR with the TaqMan
MicroRNA Reverse Transcription Kit (Lifetechnologies, Foster City, CA, USA) and specific primers for
miR-4776 (assay # 462695), 4514 (assay # 462737), 4742 (assay # 463053) and the U6 (assay # 001973)
control. Influenza matrix gene expression was quantified and reported as influenza copy number.
RT-PCR was performed using TaqMan assay with matrix-specific primers, as reported earlier [24]. The
M segment of the RT-PCR was specific for viral RNA. A standard curve was generated from the cloned
influenza IAV matrix gene by RT-PCR for IAV quantification.
2.4. miRNA Microarray
A549 cells were infected with IAV for 3 h and the RNA was extracted using the Exiqon miRCURY
locked nucleic acid (LNA) miRNA extraction kit (Exiqon, Vedbaek, Denmark). The quality of the
total RNA was verified in an Agilent 2100 Bioanalyzer profile (Agilent Technologies, Inc., Santa
Clara, CA, USA). In addition, 750 ng total RNA from both sample and reference was labeled with
Hy3 ™ and Hy5 ™ fluorescent label, respectively, using the miRCURY LNA ™ microRNA Hi-Power
Labeling Kit, Hy3 ™/Hy5 ™ (Exiqon) according to the procedure described by the manufacturer.
The Hy3 ™-labeled samples and a Hy5 ™-labeled reference RNA sample were mixed pairwise and
hybridized to the miRCURY LNA ™ microRNA Array 7th Gen (Exiqon), which contains capture probes
targeting all miRNAs for human, mouse or rat registered in the miRBASE 18.0. The hybridization
was performed according to the miRCURY LNA ™ microRNA Array Instruction manual using a
Tecan HS4800 ™ hybridization station (Tecan, Grodig, Austria). After hybridization, the microarray
slides were scanned and stored in an ozone free environment to prevent potential bleaching of the
fluorescent dyes. The miRCURY LNA ™ microRNA array slides were scanned using the Agilent
G2565BA Microarray Scanner System (Agilent Technologies) and the image analysis was carried
out using the ImaGene ®9 (miRCURY LNA ™ microRNA Array Analysis Software, Exiqon). The
quantified signals were background corrected and normalized using the global Lowess (LOcally
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WEighted Scatterplot Smoothing) regression algorithm. The data obtained were subjected to statistical
analysis and differentially regulated miRNAs in infected and uninfected cells were identified and
reported by Exiqon.
2.5. Transfection Studies
HBEpCs were transfected with a miRNA-4776 or 4514 inhibitor oligonucleotide (complementary
strand to miRNAs) or a miRNA-4776 or 4514 mimic oligonucleotide (corresponding to the
miRNA-sequence) (Life Technologies, Carlsbad, CA, USA) using the lipid-based Lipofectamine
2000 reagent diluted in Opti-MEM-I reduced serum medium (Life Technologies) according to the
protocol provided by the supplier. Briefly, HBEpCs were grown to 80% confluence in six-well plates.
Transfection complexes were directly applied to the cells (final concentration of 50 nM) and the plates
were incubated in a humidified chamber with 5% CO2 at 37 ◦ C. After 6 h of transfection, the medium
was replaced with fresh complete medium. As negative control, cells were transfected with a scrambled
oligonucleotide (Life Technologies). To evaluate the effects of miRNA-4514 and 4776 in the context
of viral infection, cells after 48 h of transfection were infected with IAV at a MOI of 1. Virus were
allowed to attach to the cells for 45 min at 37 ◦ C, then the excess virus was washed off and fresh
medium containing 1 µg/mL of TPCK trypsin (Sigma-Aldrich) was added. Cells were then incubated
for another 4 h. Following the incubation, cells were harvested at different time intervals and used for
protein and RNA studies.
2.6. Imaging with Confocal Microscopy
HBEpCs cells were grown on chamber slides overnight (Chamber slide ™, Lab-TekII, Thermo
Fisher Scientific, Rochester, NY, USA) to 80–90% confluence. Cells were then exposed to IAV for
4 h. Subsequently, cells were washed with PBS and fixed with 4% methanol-free formaldehyde
(Polysciences Inc., Warrington, PA, USA). Immunofluorescent staining was done as described
earlier [23] and stained with an antibody that recognizes the phosphorylated form of NF-κBp65,
rabbit anti-phospho-NF-κB p65 antibody (Millipore, Billerica, MA, USA) for 1 h, followed by Alexa-488
conjugated anti-rabbit secondary antibody (Life Technologies). HBEpCs overexpressing NFKBIB were
infected with IAV and then stained with NFKBIB antibody (Cell signaling, Danvers, MA, USA) and NS1
antibody (Invitrogen, Foster City, CA, USA), followed by appropriate secondary antibodies (Alexa 488
and Alexa-555). The glass slides were mounted with 40 ,6-diamidino-2-phenylindole (DAPI)-Prolong
Gold anti-fade reagent (Life Technologies) and protected with cover slips. Photomicrographs were
made using a Zeiss Laser Scanning Microscopy (LSM)-510 (Carl Zeiss AG, Obertochen, Germany)
confocal microscope.
2.7. Overexpression of NFKBIB
HBEpCs cells were transiently transfected with the open reading frame (ORF) of NFKBIB cloned in
pCMV6-Entry vector from Origene (Origene, Rockville, MD, USA) and lipofectamine 2000 (Invitrogen).
Cells transfected with an empty pCMV6 vector were used as control. Following transfection for 48 h,
cells were infected with IAV at 1 MOI for another 10 h. Cells were harvested at different time points as
described in Results and Discussion. RNA was isolated and RT-PCR for the viral matrix copy number
as well as the NFKBIB transcripts were done as described earlier.
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2.7.1. Validation of miRNA by Ago Immunoprecipitation
Immunoprecipitation (IP) of the miRNA was done according to the instructions from the kit
available from Active Motif (Active Motif, Carlsbad, CA, USA). Briefly, HBEpCs were grown to 80%
confluency in six-well plates and were transfected with 25 nM mimics of miR-4776 or miR-4514 or
a negative control (scrambled oligonucleotide of mimic or inhibitor) for 24 h. An equal number of
cells were taken for the IP to minimize variability. IP uses G-coupled magnetic beads and pan-Ago
antibody that recognizes Ago 1, Ago 2 and Ago 3 to precipitate the miRNA/mRNA complex. An
isotype antibody control was also run in parallel. IP was done as described in the manufacturer’s
protocol. The precipitated complex was collected and the RNA purified from the complex using trizol
reagent. The RNA was converted to cDNA with the High Capacity cDNA Reverse Transfection Kit
(Applied Biosystems) and specific primers for NFKBIB were used for RT-PCR. The data was analyzed
by comparing the cells transfected with mimic miRNA or negative control oligonucleotide and the fold
enrichment of NFKBIB was calculated from the Ago and isotype antibody preparations as described
by the manufacturer.
2.7.2. Luciferase Assay
The 3’ UTR sequence of NFKBIB was cloned downstream of the firefly luciferase gene.
The transcript level is regulated by its interaction with miRNAs resulting in reduced luciferase
activity that is measured by the Promega Dual Luciferase Assay (Madison, WI, USA). NFKBIB 3’ UTR
reporter plasmid was synthesized by Origene (Origene). HBEpCs cells were transfected on a 96-well
plate with a complex containing transfection agent (Lipofectamine 2000, Life Technologies), NFKBIB
UTR reporter plasmid, and 25 nM of either the miR-4776 mimic or negative control (a scrambled
oligonucleotide that is not a target of any gene). After 18 h of transfection, the medium was replaced
with complete medium and the cells were incubated for an additional 16–18 h. Cells were then collected
and lysed in lysis buffer supplied by the manufacturer. Luciferase activity was assessed in microtiter
plates using the Promega Dual Luciferase Reporter Assay system according to the manufacturer’s
instructions (Dual-Glo ®Luciferase Assay, Promega). The plates were read on a Glomax ®96-well
microplate Luminometer (Promega). The relative Renilla luciferase (Promega) activity was calculated
by normalizing transfection efficiency to the firefly luciferase activity.
2.8. Western Immunoblotting
HBEpCs were transfected with miR-4776 mimic and then mock infected or infected at a MOI
of 1 IAV. Cells were also transfected with a negative control of mimic. Four hours post infection,
the cells were lysed using a cytoplasmic protein extraction buffer containing protease inhibitors
(Thermofisher Scientific, Foster City, CA, USA). The isolated proteins were electrophoresed on a 10%
SDS-polyacrylamide gel (sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE),
Pre-cast gel, BioRad (Hercules, CA, USA). Separated proteins were transferred to a nitrocellulose
membrane (Millipore) and the membrane was blocked using Odyssey Blocking Buffer (LI-COR
Biosciences, Lincoln, NE, USA). Western blot analysis was carried out using mouse monoclonal
anti-phospho-NF-κB p65 (Millipore) and mouse monoclonal anti-GAPDH (Abcam, Cambridge, MA,
USA) and NS1 of IAV (Invitrogen). Appropriate mouse and rabbit IR Dye 680 or 800 secondary
antibodies (LI-COR Biosciences, Lincoln, NE, USA) were used. Near-infrared fluorescence detection
was performed on the Odyssey Imaging System (LI-COR Biosciences).

Viruses 2017, 9, 94

6 of 18

2.9. Viral Plaque Assay
MDCK cells were cultured in six-well tissue culture plate and incubated at 35 ◦ C in a humidified
CO2 incubator. Confluent monolayers of the cells were washed with PBS and inoculated with 800 µL of
serially diluted cell culture supernatant collected from the HBEpC cells exposed to IAV and incubated
for 45 min at 35 ◦ C. Immediately after incubation, the cells were washed twice with 2 mL of PBS,
overlaid with supplemented Dulbecco’s Modified Eagle’s medium (DMEM)/F12 containing 0.6%
agarose (Oxoid Ltd., Basingstoke , Hampshire, UK) and incubated at 35 ◦ C for another 60 h. Cells were
then fixed with 10% formalin and the agarose removed with tap water and stained with 1.0% crystal
violet and plaque forming units (PFU) were counted.
2.10. Statistical Analysis
One-way analysis of variance (ANOVA) was used to analyze RT-PCR data and post-hoc pairwise
multiple comparisons between means were performed using the Holm–Sidak method with a p-value
of <0.05 considered statistically significant using Sigma stat version 11.0 for Windows (Systat Software,
Chicago, IL, USA).
3. Results and Discussion
3.1. Microarray Analysis
The virus host paradigm provides a mechanism by which RNA viruses can regulate several
host genes through the modulation of host-specific miRNAs [25–27]. To identify influenza-induced
changes in host miRNA expression, a microarray analysis of host miRNAs differentially regulated
following IAV infection was performed. A549 cells exposed to IAV showed differential expression of
miRNAs as shown in Figure 1. We focused on the regulatory mechanisms for NF-κB expression, as it
may have a role in the replication and survival of IAV [9,10]. Little is known regarding miRNAs that
regulate the expression of NF-κB negative regulator, NFKBIB, and recent studies indicate that miR-20a
targets NFKBIB in gastric cancer cells [20]. However, miR-20a did not show any significant differential
expression in A549 cells infected with IAV. In contrast, miR-4514 exhibited a slight upregulation
and miR-4776 was downregulated in A549 cells infected with IAV (Figure 1) and target scan analysis
revealed that miR-4514 and miR-4776 are putative targets of NFKBIB (Figure 2). We added miR-4742-3p
to our validation study since it showed significant upregulation at 18 h exposure to IAV (data not
shown), and target scan predicted it as a target of NFKBIB. miRNA-4776 was of particular interest
in that two putative binding sites for this miRNA are present in the NFKBIB 3’ UTR region, one at
position 162–168 and another at position 648–654. Even though several microarray studies have shown
a wide range of miRNAs being modulated by IAV infection, very few miRNAs were studied in detail to
understand the target and role in IAV replications. Moreover, the induction of miRNA also depends on
the cell type, incubation time and the MOI of virus used. Previous studies also have shown that many
target genes of miRNAs contain several miRNA binding sites and the level of translational repression
exponentially increases with the number of miRNA binding sites in the 3’ UTR region [28]. Therefore,
this potential increase in binding of miRNA-4776 to the 3’ UTR of NFKBIB may lead to reduced
expression of this repressor and trigger increased activity of NF-κB. We further examined the role and
specificity of these miRNAs in NFKBIB expression (Table S1 shows the complete microarray data).
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Figure 1. Influenza A virus (IAV) infection induced differential expression of microRNAs (miRNAs).

Figure 1. Influenza A virus (IAV) infection induced differential expression of microRNAs (miRNAs).
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(MOI) of 1 for 4 h and samples were taken every hour, miRNAs extracted and analyzed by reverse
transcription‐polymerase chain reaction (RT‐PCR). *** p < 0.001; (B) expression pattern of miR‐4776.
transcription-polymerase chain reaction (RT-PCR). *** p < 0.001; (B) expression pattern of miR-4776.
A549 cells were infected with IAV at MOI of 1 for 4 h and samples were taken every hour, miRNAs
extracted and analyzed by RT-PCR. ** p < 0.01, *** p < 0.001; (C) expression pattern of miR-4742.
A549 cells were infected with IAV at MOI of 1 for 4 h and samples were taken every hour, miRNAs
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and analyzed by RT-PCR. Data is from three independent experiments. * p < 0.05, ** p < 0.01; and
(F) expression pattern of miR-4742. HBEpCs were infected with IAV at MOI of 1 for 4 h and samples
were taken every hour, miRNAs extracted and analyzed by RT-PCR. Data is from three independent
experiments. * p < 0.05, *** p < 0.001. Expression of each miRNA was normalized to expression of
U6 miRNA.
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miR-4776 mimic decreased the NFKBIB mRNA expression approximately 50% in uninfected cells
transfected with the negative control (Figure 5A). In contrast, the change in NFKBIB expression
in the presence of miR-4514 mimic was not consistent with a role in regulating NFKBIB mRNA
(Figure 5B). HBEpCs transfected with miR-4776 inhibitor and subsequently infected with IAV showed
an increase in NFKBIB expression, and a decrease with mimic (Figure 5C), whereas miR-4514 mimic

multiple mRNAs.
The increased expression of NFKBIB resulting from transfection of miR‐4776 inhibitor in
HBEpCs also is associated with a significant decrease in IAV matrix gene copy number as evidenced
in the 65% decrease in copy number (Figure 5E). This result is consistent with the concept that IAV is
dependent
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The increased expression of NFKBIB resulting from transfection of miR-4776 inhibitor in HBEpCs
also is associated with a significant decrease in IAV matrix gene copy number as evidenced in the 65%
decrease in copy number (Figure 5E). This result is consistent with the concept that IAV is dependent
on the NF-κB pathway [10] and the increase in NFKBIB reduced the level of active NF-κB available for
inducing the transcription of viral genes. In contrast, further decreasing the level of NFKBIB mRNA
with miR-4776 mimic did not alter the matrix copy number in infected cells, suggesting that there was
a sufficient number of NF-κB molecules to support IAV replication (Figure 5E). miRNAs are known to
induce changes in the cellular physiology by different mechanisms, and each miRNA has multiple
gene targets [29,31,32]. The exogenous administration of miRNA inhibitor to antagonize influenza
replication in airway epithelial cells could be a potential therapeutic strategy to explore for controlling
influenza infections.
Unstimulated cells contain a pool of NF-κB dimers in the cytosol that are stoichiometrically
bound with the inhibitors [16]. NFKBIB is complexed with NF-κB but upon infection or external
stimuli activated NF-κB is released [17], and subsequently translocated to the nucleus where it induces
transcription of genes. HBEpCs transfected with mimic miR-4776 followed with IAV infection for 4 h
were monitored for the expression of NF-κB by confocal microscopy (Figure 6A) and compared to the
negative control. The cells were stained with an antibody to phosphorylated NF-κBp65 that specifically
binds to the p65 component of active NF-κB (green), and the nucleus was stained with DAPI (blue).
Active phosphorylated NF-κB was significantly higher in miR-4776 transfected cells compared to the
negative control mimic transfected cells infected with IAV (Figure 6B). This data suggests that mimic
miR-4776 lowers the levels of NFKBIB mRNA and the amount of NFKBIB protein available to bind
with NF-κB results in an increased level of active NF-κB. This is consistent with previous studies that
showed NFKBIB, once released from the NF-κB/NFKBIB complex, undergoes degradation and leads
to the phosphorylation and activation of NF-κB [18,33]. We further confirmed the results obtained by
confocal microscopy with Western blot analysis. Data presented in Figure 6B shows that phosho-NF-κB
p65 is overexpressed in cells transfected with the miR-4776 mimic compared to the negative control
mimic transfected cells. The 4 h time point of infection was selected based on the results (Figures 3E
and 4A) wherein 4 h exposure to IAV showed a reduction in miR-4776 expression and upregulation of
NFKBIB transcripts. Moreover, the miR-4776 mimic transfected cells showed a reduction in NFKBIB
protein compared to the control cells transfected with negative control (Figure 6C). Taken together,
the results from this study clearly indicates that miR-4776 has a significant role in regulating NFKBIB
expression to alter the level of active NF-κB.

miR‐4776 mimic compared to the negative control mimic transfected cells. The 4 h time point of
infection was selected based on the results (Figures 3E and 4A) wherein 4 h exposure to IAV showed
a reduction in miR‐4776 expression and upregulation of NFKBIB transcripts. Moreover, the miR‐4776
mimic transfected cells showed a reduction in NFKBIB protein compared to the control cells
transfected with negative control (Figure 6C). Taken together, the results from this study clearly
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Figure 6. Immunofluorescence of IAV infected cells showing the expression of NF‐κB. (A). HBEpCs
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showing the decreased expression of NFKBIB protein in cells transfected with miR-4776 and infected
with IAV. HBEpCs transfected with miR-4776 mimic or a negative control. After 48 h of incubation, the
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To validate the role of NFKBIB, we used two classic methods: silencing of NFKBIB by small
interfering RNA (siRNA) and overexpression of NFKBIB by plasmid DNA. Four NFKBIB siRNA
oligonucleotides were obtained from Dharmacon (GE, Pittsburgh, PA, USA) but were not effective in
reducing the expression of NFKBIB mRNA in HBEpCs. All four siRNA oligonucleotides individually
or in combination failed to produce a reduction of NFKBIB transcripts (data not shown). Plasmids
carrying the ORF of NFKBIB were transiently transfected in HBEpCs. After 24–36 h of transfection,
cells were infected with IAV (1 MOI) for up to 10 h. The results (Figure 7A) indicate that there was
an increase (11–21 fold) in NFKBIB expression in cells transfected with the ORF of NFKBIB. When
HBEpCs were transfected with NFKBIB ORF plasmids, a significant reduction in IAV copy numbers
was observed (Figure 7B). Confocal analysis of the cells overexpressing NFKBIB (Red) infected with
IAV (Figure 7C) shows reduced expression of influenza NS1 protein (green) demonstrating the low
levels of IAV protein in cells. We selected influenza NS1, as it has been shown to have a significant
impact on host cell gene expression and a central role in inhibiting interferon and activating NF-κB and
PI3-K pathways [34,35]. The results from these studies show that overexpression of NFKBIB blocks
NF-κB activity needed for viral replication. The essential role of NF-κB in viral replication has been
well documented [6]. The results corroborate the effect observed with the miR-4776 inhibitor, which
increased NFKBIB expression and led to a reduction in matrix gene copy numbers. Figure 7D showed
a reduction in viable IAV in cells overexpressing NFKBIB protein compared to the control cells infected
with IAV.
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Figure 7. NFKBIB overexpression leads to reduction in IAV M gene copy number. (A) HBEpCs grown
Figure
7. NFKBIB overexpression leads to reduction in IAV M gene copy number. (A) HBEpCs grown
to 80% confluency were transfected with NFKBIB plasmid or control plasmid for 36–48 h. NFKBIB
to 80% confluency were transfected with NFKBIB plasmid or control plasmid for 36–48 h. NFKBIB
overexpressing HBEpCs were infected with 1 MOI of IAV for another 10 h, and the expression of
overexpressing HBEpCs were infected with 1 MOI of IAV for another 10 h, and the expression of
NFKBIB was analyzed using RT‐PCR. *** p < 0.001 (n = 3); (B) NFKBIB overexpressing HBEpCs were
NFKBIB
was analyzed using RT-PCR. *** p < 0.001 (n = 3); (B) NFKBIB overexpressing HBEpCs were
infected with 1 MOI of IAV for another for 10 h, and the IAV matrix gene copy numbers were analyzed
infected with 1 MOI of IAV for another for 10 h, and the IAV matrix gene copy numbers were analyzed
using the matrix gene primers, and a standard curve for the matrix gene. *** p < 0.001 (Black—Control
plasmid, Grey—NFKBIB gene overexpressing); (C) HBEpCs overexpressing NFKBIB gene were
cultured on slides and infected with IAV of 1 MOI. Cells were then fixed and stained with NFKBIB
(red) and NS1 (influenza) antibodies (green), followed by respective fluorescent secondary antibodies.
Nucleus (blue) was stained with DAPI. Slides were observed under the Laser Scanning Microscopy
(LSM)-510 confocal microscope using an oil 63X objective; (D) HBEpCs grown to 80% confluency were
transfected with NFKBIB plasmid or control plasmid for 36–48 h. NFKBIB overexpressing HBEpCs
were infected with 1 MOI of IAV for another 10 h. Culture supernatant were collected at different
time points. Percent infectious influenza virus was determined by viral plaque assay from culture
supernatant. Percent calculations were normalized to control cells infected with IAV.

3.4. miRNA Target Confirmation Studies
miRNA is incorporated with Argonaute (Ago) proteins into the RNA-induced silencing
complex [36,37], where miRNA guides the complex to partial complementary binding sites located
in the 3’ UTR regions [37] of target mRNAs to induce translational repression or degradation of
mRNAs. To confirm the specificity of miR-4776 to NFKBIB mRNA, we approached this in two
ways, using an Ago antibody pulldown method, and using a 3’ UTR luciferase assay. The Ago
protein binds the miRNA to enable the miRNA to base pair with the target mRNA [36], which can
be immunoprecipitated (IP) and separated for target identification. Ago was precipitated using a
pan-ago antibody (specific for ago-1, ago-2 and ago-3) and protein G magnetic beads (Active Motif kit).
HBEpCs were transfected with either miR-4776 or miR-4514 mimic or the negative control mimic. The
results presented in Figure 8A show a 10 fold increase in enrichment of NFKBIB mRNA obtained from
the IP of miR-4776 mimic transfected cells compared to the negative control mimic transfected cells.
Moreover, transfection of miRNA-4514 did not lead to an enrichment of NFKBIB mRNA, suggesting
that NFKBIB mRNA binds to miR-4776 and not with miR-4514.

Reporter Assay. Luciferase UTR experiments are considered the confirmatory experiments in miRNA
target identification in various studies utilizing miRNA [38,39]. The 3’ UTR of NFKBIB predicted to
interact with miR‐4776 was cloned into a reporter luciferase vector and co‐transfected with miR‐4776
mimic into HBEpC cells. Transfection of miR‐4776 mimic resulted in 80% reduction in luciferase
activity
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demonstrate that miR‐4776 regulates NFKBIB mRNA expression through binding of the 3’ UTR.
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We then addressed the specificity of miR-4776 to target NFKBIB mRNA using the 3’ UTR
Luciferase Reporter Assay. Luciferase UTR experiments are considered the confirmatory experiments
in miRNA target identification in various studies utilizing miRNA [38,39]. The 3’ UTR of NFKBIB
predicted to interact with miR-4776 was cloned into a reporter luciferase vector and co-transfected
with miR-4776 mimic into HBEpC cells. Transfection of miR-4776 mimic resulted in 80% reduction
in luciferase activity compared to that from cells transfected with the negative control (Figure 8B).
These results demonstrate that miR-4776 regulates NFKBIB mRNA expression through binding of the
3’ UTR.
Influenza viruses are a major concern due to the emergence in recent years of new and divergent
strains that are potentially dangerous including H7N9 and the pandemic 2009 H1N1. There are reports
that the virus also becomes drug resistant and the number of anti-viral drugs are limited. Therefore,
understanding the host cell’s regulatory machinery used during influenza infection has the potential
for identifying host cell targets in anti-influenza therapies. Regulation of NF-κB is a complex process,
and its regulation involves a family of inhibitor proteins (NFKBIB), which form complexes with NF-κB,
and prevents its translocation to the nucleus where activated NF-κB can affect the transcription of
target genes. We also noted that the decreased expression of miR-4776 in bronchial epithelial cells
was followed by an increase in NFKBIB mRNA and that subsequently resulted in an inactive NF-κB
protein. IAV manipulates the NF-κB pathway for efficient replication of the virus and differentially
regulates viral RNA synthesis [33]. Our data suggests that NF-κB is an important signaling molecule
that plays a critical role in the replication of IAV and is modulated by the NFKBIB protein, which, in
turn, is regulated by miR-4776.
4. Conclusions
In conclusion, the results presented here provide the first evidence that miR-4776 can modulate
the expression of NFKBIB, the regulatory protein for a key transcription factor (NF-κB) that is necessary
for cell proliferation, apoptosis and cell survival. Downregulation of NFKBIB mRNA by miR-4776 led
to the production of active NF-κB that possibly modulates the increased viral survival. Identifying
novel miRNAs for their target genes provides an alternative approach to reduce IAV infections and
block influenza transmission. Validation of specific miRNAs as potential anti-viral agents will require
further testing in animal models.
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Supplementary Materials: The following are available online at www.mdpi.com/1999-4915/9/5/94/s1, Table S1:
Microarray data on miRNA expression on A549 cells exposed to IAV for 3 h. The log fold changes in expression
of miRNAs that are up or down regulated on exposure to IAV are shown. AvgHy3-Average signal intensity,
logFC-log fold change, Control-Mock; Treatment- Infected with H1N1.
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